DEFINITIVE CONTRACT
Active75F40126C00106
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$350K
obligated · signed 2 months ago
EO 14398 - THIS PROJECT SHALL SEQUENCE AND CHARACTERIZE THE GENOME OF BDBV IN THE CURRENT OUTBREAK, WITH A SPECIFIC TARGET TO SEQUENCE AND ANALYZE THE BDBV GENOME FROM AS MANY AS 1,000 PATIENTS
Performance timeline
Start
Aug 21, 2026
End
Feb 20, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Feb 20, 2027
UNIVERSITY OF LIVERPOOL
Contract 75F40126C00106
UEI
VFHSMEHGFGG5
Parent Company
UNIVERSITY OF LIVERPOOL
Capabilities & Certifications
Headquarters Location
Current Obligation
$349,995
Base + Exercised Options
$349,995
Total Ceiling Value
$349,995
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.